Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo

Estrogen receptor negative (ER(−)) breast cancer is aggressive, responds poorly to current treatments and has a poor prognosis. The NF-κB signaling pathway is implicated in ER(−) tumorigenesis. Aspirin (ASA) is chemopreventive against ER(+) but not for ER(−) breast cancers. Nitric oxide-releasing as...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Molecules
Hlavní autoři: Nath, Niharika, Chattopadhyay, Mitali, Rodes, Deborah B., Nazarenko, Anna, Kodela, Ravinder, Kashfi, Khosrow
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6331965/
https://ncbi.nlm.nih.gov/pubmed/26184135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules200712481
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky